Omeros | OMER - Devedores Comerciais





Devedores Comerciais Alterar Data
Adma Biologics USD 158.43M 20.76M 2025-12
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Cytokinetics USD 6.83M 10.94M 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Heron Therapeutics USD 89.59M 8.54M 2025-12
Immunic USD 333K 156K 2025-12
Insmed USD 178.55M 37.7M 2026-03
Knight Therapeutics CAD 183M 7.46M 2025-12
MacroGenics USD 13.37M 55.86M 2025-12
Omeros USD 8.08M 440K 2024-06
Pacira USD 125.64M 1.57M 2026-03
Pfizer USD 16.17B 332M 2026-03
Rockwell Medical USD 10.84M 250K 2024-06
Sangamo BioSciences USD 581K 110K 2024-06
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03
Xoma USD 14.78M 4.96M 2024-06